Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:freids01

Total Results:

812


Money, Drugs, and Bodies: Examining Exchange Sex from Multiple Perspectives

Braine, Naomi; van Sluytman, Laurens; Acker, Caroline; Friedman, Sam; Des Jarlais, Don C
ORIGINAL:0013202
ISSN: 1540-4056
CID: 3610892

Syringe exchange, injecting and intranasal drug use

Des Jarlais, Don C; Arasteh, Kamyar; McKnight, Courtney; Ringer, Martin; Friedman, Samuel R
OBJECTIVE:To assess trends in injecting and non-injecting drug use after implementation of large-scale syringe exchange in New York City. The belief that implementation of syringe exchange will lead to increased drug injecting has been a persistent argument against syringe exchange. METHODS:Administrative data on route of administration for primary drug of abuse among patients entering the Beth Israel methadone maintenance program from 1995 to 2007. Approximately 2000 patients enter the program each year. RESULTS:During and after the period of large-scale implementation of syringe exchange, the numbers of methadone program entrants reporting injecting drug use decreased while the numbers of entrants reporting intranasal drug use increased (P < 0.001). CONCLUSION/CONCLUSIONS:While assessing the possible effects of syringe exchange on trends in injecting drug use is inherently difficult, these may be the strongest data collected to date showing a lack of increase in drug injecting following implementation of syringe exchange.
PMCID:5026701
PMID: 19891668
ISSN: 1360-0443
CID: 3600592

Gender and age patterns in HSV-2 and HIV infection among non-injecting drug users in New York City

Des Jarlais, Don C; Arasteh, Kamyar; McKnight, Courtney; Perlman, David; Hagan, Holly; Semaan, Salaam; Friedman, Samuel R
OBJECTIVE: To examine prevalence of and associations between herpes simplex virus type 2 (HSV-2) infection and HIV infection among never-injecting heroin and cocaine drug users (NIDUs) in New York City. METHODS: Subjects were recruited from patients entering the Beth Israel drug detoxification program. Informed consent was obtained, a structured questionnaire including demographics, drug use history, and sexual risk behavior was administered, and a blood sample was collected for HIV and HSV-2 antibody testing. RESULTS: A total of 1418 subjects who had never (lifetime) injected drugs (NIDUs) were recruited between July 2005 through June 2009. Subjects were primarily male (76%), and black (67%) or Hispanic (25%), reported recent crack cocaine use (74%), and had a mean age of 42 years. Eleven percent of males reported male-with-male sexual (MSM) behavior. The prevalence of both viruses was high: for HSV-2, 61% among the total sample, 50% among non-MSM males, 85% among females, and 72% among MSM; for HIV, 16% among the total sample, 12% among non-MSM males, 20% among females, and 46% among MSM. HSV-2 was associated with HIV (OR = 3.2, 95% CI: 2.3-4.5; PR = 2.7, 95% CI: 2.0-3.7). Analyses by gender and age groups indicated different patterns in mono- and coinfection for the 2 viruses. DISCUSSION: HSV-2 and HIV rates among these NIDUs are comparable with rates in sub-Saharan Africa. Additional prevention programs, tailored to gender and age groups, are urgently needed. New platforms for providing services to NIDUs are also needed.
PMCID:4455877
PMID: 20838366
ISSN: 0148-5717
CID: 170716

HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors

Des Jarlais, Don C; Arasteh, Kamyar; McKnight, Courtney; Hagan, Holly; Perlman, David C; Torian, Lucia V; Beatice, Sara; Semaan, Salaam; Friedman, Samuel R
OBJECTIVES: As no single HIV prevention program has eliminated HIV transmission, there is growing interest in the effectiveness of "combined" prevention programming. To compare HIV infection among persons injecting in the initial programs environment (IPE) in New York City (self-initiated risk reduction, methadone, education/outreach, and HIV testing) to HIV infection among persons injecting in a combined programs environment (CPE) (above programs plus large-scale syringe exchange). To identify potential behavioral mechanisms through which combined programs are effective. METHODS: Subjects were recruited from the Beth Israel drug detoxification program. A risk behavior questionnaire was administered and HIV testing conducted. Subjects who injected only between 1984 and 1994 (IPE) were compared to subjects who injected only between 1995 and 2008 (CPE). RESULTS: 261 IPE subjects and 1153 CPE subjects were recruited. HIV infection was significantly lower among the CPE subjects compared to IPE subjects: prevalence 6% versus 21%, estimated incidence 0.3/100 person-years versus 4/100 person-years (both p<0.001). The percentage of subjects at risk of acquiring HIV through receptive syringe sharing was similar across CPE and IPE subjects (30% versus 33%). The percentage of subjects at risk of transmitting HIV through injection-related behaviors (who were both HIV seropositive and reported passing on used needles/syringes), was much lower among the CPE subjects than among the IPE subjects (1% versus 10%, p<0.001). CONCLUSIONS: Combined prevention programs can greatly reduce HIV transmission. Reducing distributive sharing by HIV seropositive injecting drug users (IDUs) may be a critical component in reducing HIV transmission in high seroprevalence settings.
PMCID:4447191
PMID: 20163922
ISSN: 0376-8716
CID: 170717

Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas

Tempalski, Barbara; Cleland, Charles M; Pouget, Enrique R; Chatterjee, Sudip; Friedman, Samuel R
OBJECTIVES: Injection drug users (IDUs) are at high risk for HIV, hepatitis, overdose and other harms. Greater drug treatment availability has been shown to reduce these harms among IDUs. Yet, little is known about changes in drug treatment availability for IDUs in the U.S. This paper investigates change in drug treatment coverage for IDUs in 90 metropolitan statistical areas (MSAs) during 1993-2002. METHODS: We define treatment coverage as the percent of IDUs who are in treatment. The number of IDUs in drug treatment is calculated from treatment entry data and treatment census data acquired from the Substance Abuse and Mental Health Service Administration, divided by our estimated number of IDUs in each MSA. RESULTS: Treatment coverage was low in 1993 (mean 6.7%; median 6.0%) and only increased to a mean of 8.3% and median of 8.0% coverage in 2002. CONCLUSIONS: Although some MSAs experienced increases in treatment coverage over time, overall levels of coverage were low. The persistence of low drug treatment coverage for IDUs represents a failure by the U.S. health care system to prevent avoidable harms and unnecessary deaths in this population. Policy makers should expand drug treatment for IDUs to reduce blood-borne infections and community harms associated with untreated injection drug use.
PMCID:2954979
PMID: 20858258
ISSN: 1747-597x
CID: 157050

Earth-shift [Poem]

Friedman, Sam
ORIGINAL:0015163
ISSN: 1043-1268
CID: 4900432

Globalization and interacting large-scale processes and how they may affect the HIV/AIDS epidemic

Chapter by: Friedman, Samuel R; Rossi, Diana; Phaswana-Mafuya, Nancy
in: HIV/AIDS : global frontiers in prevention/intervention by Pope, Cynthia; White, Renee T; Malow, Robert (Eds)
New York : Routledge, 2009
pp. 491-500
ISBN: 0415953839
CID: 4844752

Incentives increase enrolment in substance abuse treatment at community needle exchange site [Comment]

Friedman, Catherine R; Friedman, Samuel R
PMID: 19854783
ISSN: 1468-960x
CID: 3895692

A dialogue on the incapability/capability of injection drug users

Friedman, Samuel R; Mateu-Gelabert, Pedro; Sandoval, Milagros
PMID: 20001292
ISSN: 1532-2491
CID: 3895702

Structural and social contexts of HIV risk Among African Americans

Friedman, Samuel R; Cooper, Hannah L F; Osborne, Andrew H
HIV continues to be transmitted at unacceptably high rates among African Americans, and most HIV-prevention interventions have focused on behavioral change. To theorize additional approaches to HIV prevention among African Americans, we discuss how sexual networks and drug-injection networks are as important as behavior for HIV transmission. We also describe how higher-order social structures and processes, such as residential racial segregation and racialized policing, may help shape risk networks and behaviors. We then discuss 3 themes in African American culture-survival, propriety, and struggle-that also help shape networks and behaviors. Finally, we conclude with a discussion of how these perspectives might help reduce HIV transmission among African Americans.
PMID: 19372519
ISSN: 1541-0048
CID: 3895662